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The preparation of unique wet and dry wound dressing products derived from
unprocessed human amniotic membrane (UP-HAM) is described. The UP-HAM was
decellularized, and the constituent proteins were cross-linked and stabilized before
being trimmed and packed in sterile Nucril-coated laminated aluminium foil pouches
with isopropyl alcohol to manufacture processed wet human amniotic membrane (PW-
HAM). The dry type of PD-HAM was prepared by decellularizing the membrane, UV
irradiating it, lyophilizing/freeze-drying it, sterilizing it, and storing it at room temperature.
The UP-HAM consists of a translucent yellowish mass of flexible membranes with an
average thickness of 42 µm. PW-HAM wound dressings that had been processed,
decellularized, and dehydrated had a thinner average thickness of 30 µm and lacked
nuclear-cellular structures. Following successful decellularization, discrete bundle of
fibrous components in the stromal spongy layers, microvilli and reticular ridges were
still evident on the surface of the processed HAM, possibly representing the location of
the cells that had been removed by the decellularization process. Both wet and dry HAM
wound dressings are durable, portable, have a shelf life of 3–5 years, and are available
all year. A slice of HAM dressing costs 1.0 US$/cm2. Automation and large-scale
HAM membrane preparation, as well as storage and transportation of the dressings,
can all help to establish advanced technologies, improve the efficiency of membrane
production, and reduce costs. Successful treatment of wounds to the cornea of the
eye was achieved with the application of the HAM wound dressings. The HAM protein
analysis revealed 360 µg proteins per gram of tissue, divided into three main fractions
with MWs of 100 kDa, 70 kDa, and 14 kDa, as well as seven minor proteins, with the
14 kDa protein displaying antibacterial properties against human pathogenic bacteria.
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Wet and dry wound dressings were 
produced. HAM proteins were 
purified  and analysed. The zinc 
oxide nanoparticles (HAMP-ZnO 
NP) made from HAM proteins 
were characterised and tested for 
their antibacterial activity. 
Wounds to the cornea of the eye 
healed easily when treated with 
HAM wound dressings.
Fresh human Amniotic  
membrane, Serological 
screening, selection of 
disease-free HAM, reome
stromal layer, preparation of 
HAM.
UNPROCESSED HAM
Cuboidal epithelial cells, basement 
membrane, compact layer, stromal 
and spongy layers containing 
scatted fibroblast cells are visible in 
hsitological analysis.
The flow chart depicts the 
methods for processing, and 
preparation of wet (PW-
HAM) and dry (PD-HAM) 
wound healing dressings.
HAM proteins, Nanoparticle 
synthesis (HAMP-ZnO NP) and 
analysis.
Antibacterial analysis show 
Inhibition of growth and biofilm 
formation of  pathogenic bacteria .
Processed HAM
lacked a nuclear-cellular 
epithelium, but it  did have a 
distinct fibrous elements in 
basement membrane, stromal 
and spongy layers.
Processed PW-HAM (Light 
&SEM)  showed smooth 
epithelial surface topography 
with microvilli,.
HAM dressing, wet/dry, packed, 
labelled, sterilised and processed. They  
are  durable, portable, have long 
shelf life . A slice of HAM dressing 
costs US$ 1.0 / cm² . The wound 
dressings are ready to be applied.
The dermal wounds and conjunctival 
surface can be successfully repaired 
using processed HAM wound dressings
GRAPHICAL ABSTRACT | Flow chart depicting the methods, preparing, and characterizing, by histological, and scanning electron microscopy, of wet (PW-HAM)
and dry (PD-HAM)of wound healing dressing, and preparation of nanoparticles (HAMP ZnO NP); and application of HAM wound dressing.
A wide range of antibacterial activity was observed after treatment with 75 µg/ml zinc
oxide nanoparticles derived from human amniotic membrane proteins (HAMP-ZnO NP),
including dose-dependent biofilm inhibition and inhibition of Gram-positive (S. aureus,
S. mutans, E. faecalis, and L. fusiformis) and Gram-negative bacteria (S. sonnei, P.
aeruginosa, P. vulgaris, and C. freundii).
Keywords: amniotic membrane, wound healing dress, wet/dry membrane, proteins, biofabrication, HAMP’s-ZnO
nanoparticles, antibacterial activities, biofilm
INTRODUCTION
The human amniotic membrane (HAM), which consists of
an epithelial layer, a basement membrane, and avascular
stroma, is the human placenta’s innermost layer. The HAM
can provide a pure, semipermeable membranous wound
dressing that is non-immunogenic, reduces inflammation
and pain, reduces scar tissue formation, and preserves all-
natural wound healing properties after adequate processing.
Antimicrobial properties, long-term release of a variety of
growth factors and cytokines, and the strongest skin replacement
for different wound applications are all features of these
dressings. Furthermore, processed dressing (PW-HAM/DP-
HAM) provides a favorable environment for cellular migration
and dissemination, promoting faster healing and a wide
range of wound-healing effects. Processed HAM is widely
used in tissue engineering and plastic surgery, as well as in
dermatology as a dressing for skin burns, diabetic and non-
diabetic wounds, such as leg ulcers, and in ophthalmic healing
(Davis, 1910; John, 2003; Dua et al., 2004; Gholipourmalekabadi
et al., 2015). In addition to treating cutaneous wounds, HAM
has a wide range of uses and can help restore different tissues
(Meller et al., 2011; Saghizadeh et al., 2013; Mamede et al.,
2015; Flügel et al., 2020). For protection, long-term storage,
and successful application, appropriate procedures for handling
and processing biological membranous structures such as HAM
are needed. (i) hypothermic (fresh) storage at 4◦C; (ii) cryo-
preservation at −70◦C; (iii) freeze-drying (lyophilization); and
(iv) air-drying were used as preservation methods. Although
these were the most popular preservation methods until recently,
they have drawbacks and are impractical at certain times and
in certain locations. Furthermore, it is thought that lyophilized
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HAM is best preserved with epithelial cells, which can be more
immunogenic and thus cause rejection by reactive hosts. The
immunogenic properties of lyophilized HAM can hinder the
healing process, limiting its utility in promoting cell growth
and tissue regeneration (Shortt et al., 2009). To address these
drawbacks, HAM has been decellularized and stabilized using
chemical or enzymatic methods, or a combination of both,
to remove immunogenic cellular components while selectively
stabilizing extracellular structural fibrous proteins. The biological
properties of such a “decellularized scaffold membrane” have
been demonstrated (Davis, 1910; Gipson and Grill, 1982; de
Melo et al., 2007). Several methodologies for decellularizing and
modifying the biomechanical and physico-chemical properties
of the “HAM scaffold matrix” have been established in the
past, but these methods only resulted in a compromised HAM
product (Simon et al., 2003; Rieder et al., 2004). Bader et al.
(2000) suggested a longer trypsin incubation time for more
successful decellularization, but this disrupted the HAM matrix.
To decellularize the HAM, a mixture of Tris buffer, protease
inhibitors, nucleases, and Dispase II, as well as sodium dodecyl
sulphate (SDS), was used (Wilshaw et al., 2008; Lim et al.,
2009). The HAM had previously been treated with SDS, which
had a destabilizing impact on the collagen matrix and induced
swelling throughout the elastin framework (Samouillan et al.,
1999). Dispase II treatment also caused significant changes
in the structure of HAM’s basement membrane, rendering
it unsuitable for explant culture development (Lim et al.,
2009). Treatment with EDTA and/or proteolysis may also
result in HAM damage (Saghizadeh et al., 2013; Sripriya
and Kumar, 2016). Canciello et al. (2020) acknowledged that
“An important goal that still remains to be achieved is the
identification of cultural and preservation protocols able to
maintain in time the membrane morphology and the biological
properties of its cells.” It is critical to develop improved
methods of preparation and application in order to address
difficulties and limitations in the manufacturing, preservation,
sterilization, and packaging methodologies, to maximize HAM
protection and long-term storage, and to take advantage
of the amniotic membrane’s potential benefits in a variety
of applications. Therefore, the main object of the present
investigation was to develop a novel process for preparing a
sterile, stable, inexpensive human amniotic membrane product,
free from the cellular elements of the chorion, for use as
a wound dressing in dermal and ocular applications. This
involved decellularization and cross linking of fibrous proteins,
followed by stabilization, packaging and sterilization of HAM.
Another aim of this study was to determine whether this
prepared product could be used to treat such wounds topically.
Antibacterial, antifungal, and anticancer properties have been
found in a number of peptides, proteins, essential growth factors,
and cytokines found in HAM. To broaden the therapeutic
potential of HAM, a protein extract of amniotic membrane
was combined with zinc oxide (ZnO) to form HAMP-ZnO
nanoparticles (HAMP-ZnO NP), whose antibacterial activity
was investigated.
MATERIALS AND METHODS
Screening and Collection of HAM
Fresh human placentae were obtained, with informed consent
at the time of delivery, from mothers at the caesarean facility
of the Department of Obstetrics and Gynecology, Sree Balaji
Medical College and Hospital, Chennai, India. Disease-free
placentae for HAM preparation were selected on the basis of
serological screening for detectable pathogens viz. Hepatitis B
and C viruses; HIV 1 and 2; syphilis, malaria, and Chlamydia.
Human amniotic membrane was collected from the placentae
in a sterile working area and washed with sterile Hanks’
balanced salt solution in a laminar air flow chamber to remove
excess blood and blood clots. The material was washed with
multiple changes of PBS, causing the stromal layer to swell and
thus facilitating its removal. Further processing under sterile
conditions followed the methods detailed in the flow chart
(Figure 1) (Tseng et al., 1998; Rieder et al., 2004; Fareeha et al.,
2010; Riau et al., 2010; Peter Crapo et al., 2011; Saghizadeh
et al., 2013; Mafalda, 2015). In order to free the HAM from
chorionic material and to cleanse it thoroughly from blood clots
and cellular debris it was first soaked, then rinsed numerous
times in Dulbecco’s Modified Eagle’s medium (DMEM) or in
Eagles Essential Medium (EMEM). DMEM was supplemented
with 3.3% glutamine, 4500 mg/L glucose, 110 mg/L sodium
pyruvate and 4mg/L pyridoxine hydrochloride. EMEM contained
Earle’s salts lacking Ca2+ and Mg2+, and was supplemented
with 0.584 g/L glutamine and 2.2 gm/L sodium bicarbonate.
Additionally, both DMEM and EMEM were supplemented
with antibiotics (50 µg/mL gentamicin, 50 mg/mL penicillin,
100 µg/mL ciprofloxacin, 150 µg/mL tetracycline, 100 mg/mL
of neomycin and 2.5 mg/mL of the antimycotic, Amphotericin
B). Further the decellularization of the amniotic membrane was
carried out by treating with EDTA (0.25% w/v), washing with
3% Triton X100 (0.3% w/v) in Tris-HCl buffer (10 mM, pH
8.0), washing with 0.1% EDTA at 4◦C for 48 h, incubating with
proteolytic enzyme (sterile 0.1% w/v trypsin), washing in 0.03%
EDTA solution at 37◦C, pH 7.5) for 15 h or with 0.5 M NaOH
(for 10–30 s). This was followed by repeated washings with PBS
and 0.02% EDTA for 24 h and with DMEM or EMEM which were
supplemented with antibiotics (50 ug/ml gentamicin, 50 mg/ml
penicillin, 100 µg/ml ciprofloxacin, 150 µg/ml tetracycline,
100 mg/ml of neomycin and 2.5 mg/ml of the antimycotic,
Amphotericin B).
These processes are summarized in the flow chart (Figure 1).
After spreading the decellularized AM on sterile nitrocellulose
paper (GE Health care) it was cut into pieces of 1.5 × 1.5 cm2,
3 × 3 cm2, or 5 × 5 cm2, and stored at −20◦C in small vials
containing DMEM or EMEM without Ca2+ and Mg2+ until
further use. A maximum of 15–17 HAM pieces of 5 cm size or
125–675 HAM pieces of 1 × 1 cm size were obtained from a
single placenta. All investigations on HAM were carried out as
approved by the Institutional Ethics Committee guidelines and
regulations of Sree Balaji Medical College and Hospital, BIHER,
Chennai, India.
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FIGURE 1 | Flow chart shows the processes and preparation of HAM and application.
Wet Form of PW-HAM
The decellularized HAM was cross-linked and stabilized by
treating with UV for 5 h or with a protein-protein cross-linker
(1% glutaraldehyde) for 20 min, then washed with 1 M sodium
cacodylate (pH 7.2) or 100 mM phosphate buffer (pH 7.5).
The HAM was washed repeatedly for 4 h to get rid of the
glutaraldehyde. Pieces of the amniotic membrane (1 × 1 cm2,
1.5 × 1.5 cm2, 3 × 3 cm2, 5 × 5 cm2) were cut and wrapped
with DuPontTM Tyvek R© medical grade packaging paper (Medical
Packaging Knowledge Center1). They were then packed in sterile
Nucril-coated laminated aluminum foil pouches with isopropyl
alcohol, labeled and sterilized by gamma irradiation (60Co
ray dose 25 kGy) (Genova et al., 1987; Branski et al., 2007;
FerizAdrovic, 2012; ANSI/AAMI/ISO 11137-1:2006/(R), 2010)
and the wet PW-HAM was stored in isopropyl alcohol for up to
5 years at 30◦C before use.
Dry Form of PD-HAM
The decellularized HAM was washed repeatedly with 100 mM
phosphate buffer (pH 8.5). It was then irradiated with UV at
365 nm for 5 h or was cross-linked and stabilized by treating
with 1% glutaraldehyde solution for 20 min. Following cross-
linking with glutaraldehyde it was buffer-washed repeatedly for
4 h. The processed HAM was freeze-dried (lyophilized) by rapidly
freezing the membrane, then reducing the pressure followed
by heating to sublimate the water and so form a dry wound
dressing (Kruse et al., 2000; Allen, et al., 2013). Freeze-dried
PD-HAM was wrapped in DuPontTM Tyvek R© medical packaging
paper (Medical Packaging Knowledge Center1), then packed in
sterile Nucril-coated laminated aluminum foil pouches, labeled
1www.dupont.co.in
and sterilized by gamma irradiation (60Co ray dose 25 kGy)
(Genova et al., 1987; Branski et al., 2007; FerizAdrovic, 2012;
ANSI/AAMI/ISO 11137-1:2006/(R), 2010). The packages were
stored for up to 5 years at 30◦C before use.
Histological Analysis
Unprocessed and processed samples of HAM were fixed in
neutral buffered formalin (10% v/v in 1M sodium cacodylate
buffer pH 7.2 or sodium phosphate buffer pH 7.5), washed
repeatedly to remove the fixative, dehydrated and embedded
in paraffin wax. Three µm tissue sections were cut using a
microtome, stained with Hematoxylin and Eosin (H&E) and
examined with a Carl Zeiss Microscope. The differences between
the unprocessed and processed HAM samples were analyzed (de
Melo et al., 2007; Sanluis-Verdes et al., 2015).
Scanning Electron Microscopy (SEM)
Processed and unprocessed HAM samples were fixed for 24 h
in 4% glutaraldehyde (EM grade) prepared in 1 M sodium
cacodylate buffer (pH 7.2) containing 3% sucrose and NaCl.
After fixation the tissues were washed 5 times with the buffer,
dehydrated in a graded series of ethanol (20 min in each), further
dehydrated in acetone, critical point-dried, sputter-coated with
gold palladium and finally examined in a scanning electron
microscope (Zhang et al., 2016).
Use of Wet (PW-HAM) or Dry (PD-HAM)
Dressing for Conjunctival Surface
Reconstruction
After the wound bed on the conjunctiva was prepared with
the aid of topical anesthesia, or the defective pterygium of the
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eye was surgically removed, the wet (PW-HAM) or dry (PD-
HAM) dressing was rinsed by dipping in normal sterile saline
solution and then the new membrane was applied to the wound
with the epithelial side facing outward and the membrane was
secured in place by suturing. The saline-rinsed PW-HAM or
PD-HAM was allowed to glide under the lower eyelid. The
dressing was chosen to promote epithelialization and inhibit
inflammation and angiogenesis. It was used for conjunctival
surface reconstruction, in pterygium surgery and for curing other
ocular surface problems (Prabhasawat et al., 1997; Espana et al.,
2002; Sangwan et al., 2007).
Extraction of Protein From Amniotic
Membrane and Determination of
Antibacterial Activities
The HAM was separated from the outer membrane of the
embryo, washed in a phosphate buffer (pH 8.5) and stored on
ice or at −20◦C until use. The amniotic membrane (1800 gm)
was homogenized, sonicated, and centrifuged at 10000 RPM
for 15 min. The resulting protein-containing extract (HAMPE)
was frozen at –80◦C (Shao et al., 2004). Protein density was
measured by using a nano-drop ND-1000 spectrophotometer,
ThermoFisher Scientific, United States. The protein extract
prepared from the UP-HAM was purified by using AKTA pure
-Sephadex ion-exchange column chromatography (Wipro GE
Healthcare Pvt Ltd, Life Sciences). The protein extract of the UP-
HAM was subjected to SDS-PAGE protein analysis (Laemmli,
1970) in a discontinuous buffer system at pH 8.3. The UP-
HAM protein sample was mixed with sample buffer (2X) in
1:1 ratio, heated in a boiling water bath for 5 min, loaded into
the SDS-PAGE 10% as separating gel and 4% polyacrylamide as
stacking gel and run at a constant voltage (60 V) for 6–8 h. After
protein separation, the gel was incubated in 10% Trichloroacetic
acid (TCA) for 60 min to fix the HAM proteins, stained with
Coomassie brilliant blue/amido black for 6 h at room temperature
followed by de-staining and the gels were stored in 7% acetic
acid. The molecular weight of the HAM proteins was determined
with molecular weight markers by using Gel Doc 2000 (BioRad)
software. Antibacterial inhibitory effects of the HAMPE/purified
proteins (HAMP’s) on the growth of bacteria were determined by
adopting the well diffusion assay method of Bauer et al. (1966).
The column-purified 14 kDa protein of UP-HAM was loaded
(25, 50, and 75 µg protein/mL) into the wells of Mueller Hinton
agar (MHA) plates, seeded with 20 µl of bacterial cultures of
Pseudomonas aeruginosa (106 cell/mL) incubated at 37◦C for 24 h
and the zone of inhibition was determined.
Synthesis of HAMP-ZnO NP
Reduction of zinc acetate dehydrate to zinc oxide nanoparticles
was carried out following the co-precipitation method of Singh
et al. (2011) with slight changes. In brief, 2 M zinc acetate was
prepared in 50 mL of deionized water with vigorous stirring.
Five ml of HAMPE was added and the mixture was stirred
continuously with a magnetic stirrer for 3 h. The resultant white
precipitate was filtered and washed carefully with double distilled
water to remove impurities. The white powder obtained was dried
using a vacuum desiccator at 27± 3◦C.
Characterization of HAMP-ZnO NP
The HAMP-ZnO NP suspension (1.5 mL of aliquots) was
sonicated for uniform dispersion, and evaluated by measuring
the UV spectrum in a cuvette. The aqueous components
were analyzed in the range 200–600 nm using an UV-Vis
spectrophotometer (UV-1800; Shimadzu, Japan). A solution of
zinc acetate (2 mM) was used as blank. The crystalline nature of
HAMP -ZnO NPs was determined by X-ray diffraction (Powder
X-ray diffractometer, X’ Pert Pro-P Analytic). The scanning was
performed in the region of 2-THETA from 30◦ to 90◦. For FTIR
(Fourier Transform Infrared Spectroscopy) studies, HAMP-ZnO
NPs (1 mg) were mixed separately with 100 mg of spectroscopic
grade KBr in about 1:100 proportion. The mixture was then
compressed into a 2 mm semi-transparent disk by applying a
force of 10 T for 2 min. The FTIR spectra were recorded in
the wavelength of 400–4000 cm−1 at a resolution of 4 cm−1
(PerkinElmer, Shelton, CT, United States).
Antibacterial Activity of HAMP-ZnO NP
(Well Diffusion Assay)
The antibacterial activity of HAMP-ZnO NP was evaluated
against Gram positive bacteria (Staphylococcus aureus,
Streptococcus mutans, Enterococcus faecalis, and Lysinibacillus
fusiformis) and Gram-negative bacteria (Shigella sonnei,
Pseudomonas aeruginosa, Proteus vulgaris, and Citrobacter
freundii) by well diffusion assay. HAMP-ZnO NP (25, 50, and
75 µg/mL) were loaded into the wells of Mueller Hinton agar
(MHA) plates seeded individually with 20 µl of one of the
targeted bacterial cultures (106 cell/mL). The plates in triplicates
were kept in an incubator at 37◦C for 24 h and the zone of
inhibition around the wells indicating the antibacterial activity
of HAMP’s -ZnO NPs was measured in diameter (mm) and were
compared with control experiments. A zone of inhibition was
determined both in controls [Zinc acetate (75 µg mL−1)] and in
the HAMP-ZnO NPs (75 µg/mL) against harmful bacteria such
as E. faecalis, S. aureus, P. aeruginosa, P. vulgaris, S. mutans, S.
sonnei, L. fusiformis, and C. freundii.
Antibiofilm Activity of HAMP-ZnO NP
The biofilm thickness of Gram positive (S. aureus, S. mutans,
E. faecalis, and L. fusiformis) and Gram-negative bacteria
(S. sonnei, P. aeruginosa, P. vulgaris, and C. freundii) and
the antibiofilm efficacy of HAMP’s -ZnO NPs were evaluated
through CLSM (Confocal Laser Scanning Microscopy) analysis.
Quantitative assessment of biofilm inhibition in the presence
of HAMP’s -ZnO NPs was performed in 24 well polystyrene
plates. In brief, sterilized glass pieces were aseptically introduced
into the wells of 24 well plates containing 20 µl of known
cultures in 1. 5 mL of Luria Bertani broth supplemented with
HAMP’s -ZnO NPs at 25, 50, and 75 µg/mL individually.
Control was maintained with bacterial cultures alone and the
plate was incubated for 24 h at 37◦C. After incubation, the
used media was gently removed from the 24 wells and the
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 5 July 2021 | Volume 9 | Article 695710
fbioe-09-695710 July 22, 2021 Time: 16:39 # 6
Ramasamy et al. HAMP-ZnO Nanoparticles HAM Wound Dressing
glass pieces were washed thrice with 0.1 M PBS to remove
loosely attached bacterial cells and other polluting materials.
The plate was air dried for 15 min and the glass pieces
were stained with 0.4% acridine orange. Prior to visualization,
the excess of stain was removed and air-dried. The images
of the stained-glass pieces were observed under CLSM (LSM
710, Carl Zeiss, Zana, Germany) equipped with an excitation
filter 515–560 and magnification at 20×. For light microscopy
analysis, the glass pieces were stained with (0.1%) crystal
violet and after air-drying were examined microscopically at
40 x magnifications.
RESULTS
Light and Scanning Electron Microscopy
of Unprocessed and Processed HAM
Unprocessed HAM appears as a yellowish transparent mass of
flexible membranes with an average thickness of 42 µm when
removed from the chorion (Figures 2A,B). The epithelium
is preserved as a single layer of cuboidal cells varying in
thickness from 5 µm to 10 µm in samples freshly isolated and
stored in 70% ethanol, underneath which is a dense acellular
basement membrane composed of reticular fiber, preceded by
a fibrous avascular stroma of connective tissues consisting of a
compact layer, stromal and spongy layers (Figure 2B). Cuboidal
epithelial cells, fibrous basement membrane, and a spongy
stromal layer containing scatted fibroblast cells were visible
in Hematoxylin and Eosin-stained portions of unprocessed
HAM sheets (Figure 2B). Hematoxylin was used to dye the
nuclei of cells in the epithelium and stromal layers, while
Eosin was used to stain the cytoplasm (Figure 2B). The
dried, decellularized, dehydrated HAM was thinner than the
unprocessed HAM, varying in thickness from 20 µm to 40 µm
with an average thickness of 30 µm and lacking a cellular
epithelium (Figures 2C,D, Figures 3A,C). The fibrous basement
membrane and a distinct bundle of fibrous components in
the stromal spongy layers, such as thick longitudinal and
thin fibers, persisted (Figures 2C,D, Figures 3B,C). Nuclear-
cellular structures were missing from the dried, decellularized
HAM membrane (Figures 2C,D). The decellularized, refined
HAM wound dressing presented a smooth, fibrous, and glassy
transparent appearance (Figures 3A–C). The processed PW-
HAM dressing had a relatively smooth and flat surface
topography with microvilli and reticular ridges on a fine matrix,
as seen in SEM micrographs (Figures 4A–C). Some regions
of the surface lacked microvilli and had pit-like depressions
(Figures 4A,B), which might represent the locations of epithelial
cells lost during the preparative processes. Cross-linking with
glutaraldehyde solution for 20 min, followed by washing with
buffers (1M sodium cacodylate buffer for 4 h) contributed to the
biomembrane’s stability and retention of biological and wound
healing properties. The cost of production of a slice of HAM
dressing is 1.0 US$/cm2. The HAM wound dressing can be stored
at room temperature (30◦C) for 3–5 years, is portable, and is
available throughout the year.
Use of PW-HAM/PD-HAM for
Conjunctival Surface Reconstruction
The new membrane was found to be securely attached to the
conjunctiva seven days after a processed PW-HAM/PD-HAM
dressing was applied to the surgical wound caused by removal of
a nasal pterygium. The development of a functional epithelium
was complete after 21 days, and the applied membrane appeared
to dissolve and vanish. Figures 5A–C depict the pre-operative
and post-operative appearances of the eye, as well as the location
of the processed HAM during surgery. This study found that
processed human HAM membrane can be used to successfully
repair the conjunctival surface after a nasal pterygium is
surgically removed.
Extraction of Protein From UP-HAM and
Determination of Antibacterial Activities
The protein density of the UP-HAM extract was 360 µg of protein
per gram of tissue. AKTA pure-Sephadex ion-exchange column
chromatography was used to further purify the protein extract.
PAGE analysis showed the existence of three prominent proteins,
with molecular weight of 100, 70, and 14 kDa (Figure 6). In
addition, the Coomassie Brilliant Blue-stained gels revealed the
presence of six or seven other minor proteins. When applied to
a culture plate of Pseudomonas aeruginosa, the 14 kDa purified
protein of UP-HAM was found to have antibacterial activity,
creating a zone of inhibition (Figures 7A,B). A zone of inhibition
(in mm) was found both in controls Zinc acetate (75 µg/mL−1)
and HAMP-ZnO NPs (75 µg/mL) against harmful bacteria such
as E. faecalis, S. aureus, P. aeruginosa, P. vulgaris, S. mutans, S.
sonnei, and C. freundii, albeit the zone of inhibition was much
greater in HAMP-ZnO NPs (Figure 7A; see Tables 1, 2).
Characterization of HAMP-ZnO NPs
The synthesized HAMP-ZnO NPs had a sharp peak at 300 nm,
according to UV spectroscopic analysis (Figure 8A). X-ray
diffraction analysis confirmed the crystalline structure of HAMP-
ZnO NPs (XRD). In the 2-THETA range between 10◦ and 80◦,
XRD analysis of HAMP-ZnO NPs revealed Bragg’s reflection
peaks at 31.7, 34.3, 36.1, 47.4, 56.5, 62.7, and 69.9 (Figure 8B).
These peaks were designated the diffraction lattice plates (100),
(002), (101), (102), (110), (103), and (201), suggesting the
existence of a crystalline structure with hexagonal wurtzite-
shaped functional groups in HAMP-ZnO NPs. The XRD research
findings match those recommended by the Joint Committee on
Powder Diffraction Standards (JCPDS 75-0576). In the range of
400–4000 cm−1, the FTIR spectrum of HAMP-ZnO NPs was
identified, revealing the existence of certain functional groups
in the biosynthesized nanoparticles (Figure 8C). N-H stretching
vibrations of amide groups in the protein lead to the band at
3442 cm−1. The peak at 2924 cm−1 is a C-H stretching vibration,
while the peaks at 1644 cm−1 and 1434 cm−1 are carbonyl stretch
and N-H stretch vibrations resulting from the protein’s amide II
linkages. The existence of amine groups is indicated by the band
at 1062 cm−1. The ZnO stretching mode is correlated with the
band at 456 cm−1. These findings signify the active participation
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FIGURE 2 | (A) A photograph depicts a bright yellowish tinted mass of fresh unprocessed human amniotic membranes (UP-HAM) that is slimy, flexible, and
transparent. (B) A part of an unprocessed amniotic membrane (UP-HAM) stained with Hematoxylin and Eosin is shown in a light micrograph. There are cuboidal
epithelial cells, a fibrous basement membrane, a stroma made up of a compact layer, a stromal layer made up of scatted fibroblast cells in a fibrous matrix, and a
spongy layer. Hematoxylin is used to stain the nuclei of epithelial cells. Cells of the fibroblast (F). (C) Displays a cross-sectional view of the processed decellularized
unique PD-HAM membrane stained with Hematoxylin and Eosin (H&E). In the decellularized, dehydrated, processed PD-HAM, there are bundles of fibrous
components present in the compact, stromal, and spongy layers, as well as the absence of nuclear-cellular structures. With H&E, the epithelial layer is often stained
black. (D) Displays a cross-sectional view of the processed decellularized PD-HAM membrane stained with Hematoxylin and Eosin (H&E). In the decellularized,
dehydrated, processed DP-HAM, bundles of fibrous components (unique α and β long fibers) can be seen, as well as the absence of nuclear-cellular structures.
Hematoxylin and Eosin is used to stain the decellularized epithelial layer. AGC stands for apical membrane glycocalyces, BM stands for basement membrane, and
mv-r stands for microvillous ridge.
of the aforementioned functional groups in the HAM proteins
present in HAMP -ZnO NPs.
Antibacterial Potential of HAMP-ZnO
NPs
HAMP-ZnO NPs demonstrated strong antibacterial activity
against targeted bacteria as compared to control wells without
the nanoparticle preparation (Figures 7A,B). Table 1 shows the
diameters of inhibition zones for Gram positive and Gram-
negative bacteria after exposure to 75 µg/mL of HAMP-
ZnO NPs. HAMP-ZnO NPs is found to be effective against
both Gram positive and Gram-negative bacteria. The 14 kDa
protein adsorbed on the nanoparticles’ surface is thought to be
responsible for HAMP-ZnO NPs’ antibacterial effectiveness.
Antibiofilm Activity of HAMP-ZnO NPs
Gram-positive (S. aureus, S. mutans, E. faecalis, and L. fusiformis)
and Gram-negative bacteria (S. sonnei, P. aeruginosa, P. vulgaris,
and C. freundii), both untreated controls and treated with
HAMP -ZnO NPs, had their biofilm morphology assessed using
light microscopy (crystal violet stain) and CLSM analysis (0.4%
acridine orange nuclear stain). The findings are shown in
Figures 9A–D. The biofilms treated with HAMP-ZnO NPs had
a substantial reduction in thickness and coverage compared
to the untreated control preparations, which showed complex
multilayers of cells with good affinity to the substratum. With
increasing concentrations of HAMP-ZnO NPs and incubation
time, the inhibitory impact on biofilm thickness and coverage
was stronger. As a result, HAMP-ZnO NPs inhibited biofilm
formation in a dose-dependent manner.
DISCUSSION
The current study describes an updated processing and
development procedure for stabilized, dry and wet formulations
of a HAM wound dressing for topical application. These HAM
wound dressings, both wet and dry, are inexpensive, readily
available, easy to store and transport at room temperature,
and can be used anywhere on the planet. Other similar
preparations have been confirmed to produce inconsistent,
ineffective, and substandard products, unlike the HAM wound
dressings mentioned here. The preparation methods for HAM
wound dressings, especially de-epithelialization, vary. EDTA,
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FIGURE 3 | (A) A translucent PW-HAM wound dressing unpacked from the DuPontTM Tyvek R© medical grade packaging paper and sterile Nucril coated laminated
aluminum foil pouch. (B) A light micrograph showing a smooth surface view of the matrices of the processed PW-HAM wound dressing. (C) A light micrograph
shows fibrous nature (unique long and short fibers) of the matrices of the processed PW-HAM wound dressing.
FIGURE 4 | (A) SEM micrograph shows microvilli (mv) on the amniotic epithelial surface of the processed PW-HAM wound dressing. Surface area of some amniotic
epithelial surface lacking microvilli shows depressions (ACD) with pit-like structures (CP) and reticular ridges (rr). (B) SEM micrograph of the amniotic epithelial surface
of the processed PW-HAM wound dressing indicate the occurrence of microvilli. Some epithelial surface lacks microvilli but have pit-like depressions (CP). (C)
Microvilli (mv) or reticular microvilli (rmv) of the amniotic epithelial surface of the processed PW-HAM wound dressing are visible in a magnified SEM micrograph.
Trypsin-EDTA, Urea, Thermolysin, Ethanol, Hypotonic Buffer,
SDS, and Nuclease have been used in this crucial step in the
preparation (Jirsova and Jones, 2017; Ferenczy and Souza, 2020).
In the present report, a mixture of non-ionic detergents,
alkali, and enzymatic treatments was used to fully decellularize
the HAM while preserving the anatomical features of the
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FIGURE 5 | (A) A photograph depicts the removal of a Nasal Pterygium from the right eye during surgery. (B) Preoperative photograph of the right eye showing
nasal Pterygium, a mucous membrane that protects the white portion of the eye and extends into the cornea. (C) After 1 month, the post-operative right
eye-pterygium has fully healed and the wounds have healed completely.
FIGURE 6 | Purified Human amniotic membrane proteins (HAMPs) on SDS-PAGE with a 10% separating gel and a 4% polyacrylamide stacking gel. MM stands for
protein molecular weight marker, and Lane II-IV stands for purified HAMPs (Note the presence of 14–113 kDa proteins).
basement membrane and avascular stroma. The decellularized
and stabilized HAM dressing was found to be transparent, solid,
and flexible, allowing it to conform to tissue contours in any
anatomical position where it was applied as a wound dressing.
The chelating agent EDTA aided metal ion sequestration and
dissolution of immunogenic protein–protein linkages, resulting
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FIGURE 7 | (A) depicts a zone of inhibition of HAMP-ZnO NPs against Gram positive (Staphylococcus aureus, Streptococcus mutans, Enterococcus faecalis and
Lysinibacillu, fusiformis) and Gram-negative bacteria (Shigella sonnei, Pseudomonas aeruginosa, Proteus vulgaris and Citrobacter freundii). (B) shows a zone of
inhibition of the 14 kDa protein of HAMPs against Pseudomonas aeruginosa.
TABLE 1 | The zone of inhibition (mm) of HAMP-ZnO NPs against pathogenic bacteria viz. C. freundii, E. faecalis, L. fusiformis, P. aeruginosa, P. vulgaris S. aureus,
S. mutans, S. sonnei are detailed.
S. No. Bacterial strains Accession numbers Concentrations of HAMP-ZnO NPs
25 µg/mL 50 µg/mL 75 µg/mL
Zone of inhibition (mm)
1 Proteus vulgaris HQ116441 2.0 ± 0.3 3.0 ± 1.1 4.0 ± 1.1
2 Pseudomonas aeruginosa HQ 4006631 3.0 ± 0.2 3.0 ± 1.2 4.0 ± 1.2
3 Lysinibacillus fusiformis KF886273 1.3 ± 0.3 4.3 ± 1.1 4.3 ± 1.1
4 Shigella sonnei ATCC-25175 1.3 ± 0.3 4.3 ± 1.1 4.3 ± 1.1
5 Citrobacter freundii KC465905 2.0 ± 0.3 4.0 ± 1.1 5.0 ± 1.1
6 Staphylococcus aureus HQ693279.1 3.1 ± 0.1 5.1 ± 0.4 5.1 ± 0.4
7 Enterococcus faecalis MTCC-9542 3.0 ± 0.2 4.0 ± 0.4 6.0 ± 0.4
8 Streptococcus mutans K7769531 2.0 ± 0.3 4.30 ± 1.1 7.0 ± 1.1
The antimicrobials activity of the HAMPs was evaluated by the formation of a microbial zone of inhibition technique which showed a clear zone of inhibition (Figures 6A,B:
Table 1). An increase in the zone of inhibition exhibited by the bacterial pathogens varied with increase in concentration of HAMPs. The maximum zone of inhibition
exhibited by S. mutans was (7.0 ± 1.1 mm), followed by E. faecalis (6.0 ± 0.4 mm), S. aureus (5.1 ± 0.4 mm), C. freundii (5.0 ± 1.1 mm), S. sonnei and L. fusiformis
(4.3 ± 1.1 mm), and P. vulgaris (4.0 ± 1.1 mm).
in epithelial cell disaggregation and dissociation from the HAM
extracellular matrix (Aplin, 2003; Bacakova et al., 2004; Bhatia
et al., 2007; Koley and Bard, 2010; Peter Crapo et al., 2011;
Allen, et al., 2013; Fu et al., 2014; Mafalda, 2015; Sripriya and
Kumar, 2016). After treating the HAM with the protein-digesting
enzyme trypsin, peptide bonds were hydrolyzed and some of
the complex proteins were broken down into smaller peptides.
Triton-X100 disrupted hydrophobic polar head groups involved
in hydrogen bonding in cellular lipid bilayers, allowing the HAM
to be decellularized more easily. At low concentrations of TX100,
the detergent monomer is known to be incorporated into lipid
membranes, causing disruption and release of cellular contents.
When cells are exposed to large quantities of TX100 for an
extended period of time, the membrane permeabilization and
structural failure are irreversible (Aplin, 2003; Bacakova et al.,
2004; Bhatia et al., 2007; Koley and Bard, 2010; Allen, et al., 2013;
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TABLE 2 | The inhibition zones (mm) of Zinc acetate (control) and HAMP-ZnO NPs against pathogenic bacteria are detailed.
S. No Bacteria strains and accession numbers Zinc acetate (75 µg mL−1) Concentrations of HAMP-ZnO NPs 75 µg/mL
Zone of inhibition (mm)
1 Streptococcus mutans K7769531 2.8 ± 0.1 7.0 ± 1.1
2 Enterococcus faecalis (MTCC-9542) 3.1 ± 0.1 6.0 ± 0.4
3 Staphylococcus aureus (HQ693279.1) 3.0 ± 0.4 5.1 ± 0.4
4 Pseudomonas aeruginosa (HQ 4006631) 2.3 ± 0.1 4.0 ± 1.2
5 Proteus vulgaris (HQ116441) 3.3 ± 0.2 4.0 ± 1.1
6 Shigella sonnei (ATCC-25175) 2.0 ± 0.2 4.3 ± 1.1
7 Citrobacter freundii (KC465905) 2.6 ± 0.1 5.0 ± 1.1
Both Zinc acetate and HAMP-ZnO NPs showed antimicrobial efficacy against pathogenic bacteria such as E. faecalis, S. aureus, P. aeruginosa, P. vulgaris, S. mutans,
S. sonnei, and C. freundii. The zone of inhibition was greater in HAMP-ZnO NPs than in Zinc acetate in all bacterial species investigated, though it varies per
bacterial pathogen.
Fu et al., 2014; Mafalda, 2015). Human amniotic membrane
was previously treated with 1 percent Trypsin/EDTA, which
eliminated epithelial and mesenchymal cells while keeping the
basal membrane and extracellular matrix intact. The latter was
mechanically powerful, had anti-inflammatory, anti-microbial,
anti-fibrotic, anti-scarring, and biocompatibility properties, but
had only a minor immunogenicity (Rieder et al., 2004; Young
et al., 2005; Baguneid et al., 2006; Bhatia et al., 2007; Lim et al.,
2009; Peter Crapo et al., 2011; Caruso et al., 2013; Mamede
et al., 2015; Sanluis-Verdes et al., 2015; Zhang et al., 2016).
The protection of essential molecules such as anti-inflammatory
cytokines, growth factors, and extracellular matrix factors, as
well as the structural integrity of the non-cellular matrix,
should be the focus of future advances in the processing and
stabilization of HAM for wound dressing. The results of the
current study show that freeze drying HAM and preserving wet
HAM wound dressings in isopropyl alcohol are the best methods
for producing high-quality wound dressings. Furthermore, HAM
wound dressings, whether wet or dry, are cost-effective, simple to
collect, store, and transport at 30◦C, and can be used anywhere in
the world. Tseng and Tsubota’s (2002) procedures, on the other
hand, involve freezing and storing pieces of HAM membrane
FIGURE 8 | (A) In the synthesized HAMP’s-ZnO NPs, the UV Spectroscopy spectrum shows a sharp peak at 300 nm. (B) The reflection peaks of the synthesized
HAMP Zinc oxide nanoparticles can be seen in the XRD spectrum. (C) The peaks of the functional groups of the synthesized Zinc oxide nanoparticles can be seen in
the FTIR spectrum.
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FIGURE 9 | (A,B) Light micrographs show the antibiofilm activity of HAMP-ZnONPs (50 µg/ml and 75 µg/ml) against (A) Gram positive (Staphylococcus aureus,
Streptococcus mutans, Enterococcus faecalis and Lysinibacillus fusiformis) and (B) Gram negative bacteria (Shigella sonnei, Pseudomonas aeruginosa, Proteus
vulgaris and Citrobacter freundii). The cells were stained with crystal violet. (C,D) Confocal laser scanning micrographs show the antibiofilm activity of HAMP-ZnO
NPs (75 µg/ml) against (C) Gram positive (Staphylococcus aureus, Streptococcus mutans, Enterococcus faecalis and Lysinibacillus fusiformis) and (D) Gram
negative bacteria (Shigella sonnei, Pseudomonas aeruginosa, Proteus vulgaris, and Citrobacter freundii). The cells were stained with acridine orange.
in 50% glycerol in Dulbecco’s Modified Eagle Medium for up
to 2 years, after which the membrane product must be thawed
at room temperature and washed with normal buffered saline
solution before use (Tseng et al., 1999; Tseng and Tsubota, 2002).
In another procedure, the HAM membrane was first washed
with dimethyl sulfoxide (DMSO) (0.5 M) 4% w/v in 0.01M
phosphate-buffered saline solution (PBS), then MDMSO (8% w/v
in 0.01 M PBS), and finally 1.5 M DMSO (12% w/v in 0.01 M PBS)
(Tseng and Tsubota, 2002). As a result, the manufacturing and
preparation methods for dry and wet HAM wound dressings, as
well as the preservation and transportation conditions, differed
significantly. In a number of climatic, economic, and geographic
conditions, there is no standard operating procedure for various
arrangements, storage, and transportation of HAM dressings.
An automated universal process for production of HAM wound
dressing preparations would improve the quality and quantity of
the membrane for use, which could be crucial in assuaging users’
concerns and ensuring that the wound dressing is safe and widely
accepted. Several layers were evident in both the unprocessed
and processed HAMs using light microscopy and SEM. UP-
HAM is a transparent yellowish mass of flexible membranes
with an average thickness of 42 µm, according to the present
study. Unlike UP-HAM, PW-HAM wound dressings were dried,
decellularized, and dehydrated, with a thinner average thickness
of 30 µm and no nuclear-cellular structures, appearing as a
smooth, fibrous, and glassy translucent layer. An epithelial layer
of cuboidal cells with hematoxylin-stained nuclei, as well as
fibroblast cells in the stroma, were found in UP- HAM. Despite
the fact that the decellularization process was effective because
the processed HAM had no cells with stained nuclei, microvilli
and reticular ridges were visible on a relatively smooth and
flat amniotic surface. The current results are consistent with
previous findings on unprocessed HAM, which revealed a layer
of cuboidal epithelial cells, a fibrous basement membrane layer,
a stromal fibrous layer with occasional fibroblast cells, and
a spongy layered system. A high concentration of hydrated
proteoglycans and glycoproteins, as well as type I and III collagen,
was identified in the spongy sheet. Anti-angiogenic and anti-
inflammatory proteins were present in the AM’s epithelial and
mesenchymal cells, on the other side (Koizumi et al., 2000; Rieder
et al., 2004, 2006; Hopkinson et al., 2006; Wilshaw et al., 2008;
Liang et al., 2009; Peter Crapo et al., 2011). The denudation
protocol used in this study involved removing cuboidal amniotic
epithelial cells and other cells with a detergent, sodium dodecyl
sulphate (SDS). More research is required to better understand
the process of “synthetic HAM membrane preparation” and to
establish better methods for completely extracting immunogenic
components while preserving the stromal components’ molecular
integrity. The cost of manufacturing a slice of HAM dressing
was 1.0 US$/cm2, according to the actual figures derived from
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the current study. The Z-AM-3 × 3 dry amniotic membrane
(3 cm × 3 cm) from Zabbys cost $100.00. (Cost of Dry Amniotic
Membrane – Zabbys). The cost of amniotic membranes, on
the other hand, ranged from $300 to 900 per device, putting
a strain on patients who are paying out of pocket (Gutiérrez-
Moreno et al., 2011; Voigt and Anderson, 2019: Voigt, 2020).
Automation and large-scale HAM membrane preparation, as
well as storage and transportation of the dressings, can all help
to establish advanced technologies, improve the efficiency of
membrane production, and reduce costs. Moreover, the HAM
wound dressing can be stored for 3–5 years at room temperature
(30◦C), is compact, and is available all year.
The protein content of the UP-HAM was revealed to be
360 µg proteins/gm of HAM tissue in the current research.
Three prominent proteins with molecular weights of 100 kDa,
70 kDa, and 14 kDa, as well as seven minor proteins, were
discovered using SDS-PAGE. One of these purified proteins (the
14 kDa component) was found to have antibacterial activity
against human pathogenic bacteria, indicating that HAM wound
dressing could be used to prevent bacterial infection. Several
other proteins contained in amniotic membrane extract have
been shown to have antimicrobial and other functions (Yadav
et al., 2017; Ramuta et al., 2020). Hopkinson et al. (2006)
found that thrombospondin, mimecan, BIG-H3, integrin alpha
6 extracellular matrix-associated, and cell structural proteins had
a substantially lower protein content. On fresh UP-HAM and
samples taken at every stage of the processing and preparation,
2D analysis and protein microarray studies can help explain
protein dynamics, including molecular and structural changes.
The efficient synthesis and use of Zinc oxide HAMP-ZnO NPs
using protein extract from the unprocessed human amniotic
membrane was demonstrated in the current study. Bragg’s
reflection peaks were identified in the HAMP-ZnO NPs after
XRD analysis. The study revealed a crystalline structure with
functional groups in a hexagonal wurtzite form. The observations
of the present study were in agreement with previous findings
on zinc-oxide nanoparticles (Le-ZnO-NPs) and CS/Ag/ZnO
nanocomposite (Thaya et al., 2016; Vijayakumar et al., 2019).
Purification, peptide and NP synthesis, as well as characterization
and antimicrobial testing of protein fragments isolated from
human amniotic membrane stem cells, are all important
requirements in the establishment of innovative antibacterial
molecules and applications.
The HAMP-ZnO NPs were also found to have significant
antibacterial activity against Gram positive and Gram-negative
bacteria. The concentration of HAMP-ZnO NPs was found to
increase the clear zone of inhibition, a measure of antimicrobial
activity. Furthermore, the inhibition zone for Gram positive
bacteria was larger than that for Gram negative bacteria (see
Table 1). Naskar et al. (2020) also found that AZO NPs had
lower antibacterial activity against Gram-negative bacterial cells
E. coli and A. baumannii than S. aureus, despite MRSA3 and
MRSA6 being more resistant. Despite the fact that antibacterial
activity of ZnO NPs and Zn2+ ions has been reported, the
exact mechanism of antibacterial activity is unknown. ZnO NPs
and Zn2+ ions are thought to inhibit genomic DNA/plasmid
replication and influence the development of bacterial cell
membrane proteins/enzymes, resulting in cell death. The ability
of the synthesized HAMP-ZnO NPs to kill Gram-positive
and Gram-negative bacteria demonstrates the preparation’s
broad antibacterial capacity, but further in vitro and in vivo
research is needed to determine their full potential for infection
control.
The anti-biofilm potential of HAMP-ZnO NPs was found
to be proportional to both the concentration and the length
of incubation with the nanoparticles. The thickness of the
biofilms for both Gram positive and Gram-negative bacteria
was decreased after treatment with nanoparticles. In the absence
of the HAMP-ZnO NPs, the control cultures revealed highly
complex multilayered biofilms with a strong affinity for the
substrate. When Gram positive bacteria (Bacillus licheniformis
and Bacillus cereus) and Gram-negative bacteria (Bacillus niger)
were treated with CS/Ag/ZnO nanocomposite at 8 µg mL−1
they were found to have antibacterial activity and repress biofilm
formation (Vibrio parahaemolyticus, and Proteus vulgaris).
Candida albicans biofilm formation was also inhibited by the
CS/Ag/ZnO nanocomposite at 50 µg mL−1 (92%) (Thaya
et al., 2016; Vijayakumar et al., 2019). Jain et al. (2020)
successfully synthesized ZnO nanoparticles that had excellent
antimicrobial activity and applicability against Xanthomonas
oryzae pv. oryzae and Alternaria sp. Green silver nanoparticles
in a hybrid biological nano-scaffold cross-linked HAM, as well
as the extract and Human Amnion Membrane Composites,
improved antibacterial properties and wound healing, as well
as their biomedical applications (Ramesh et al., 2017; Yadav
et al., 2017; Palanker et al., 2019; Dadkhah Tehrani et al., 2021).
Therefore it can be concluded that HAMP-ZnO nanoparticles
(NPs) containing human amniotic membrane protein may have
antimicrobial activity against a wide range of Gram positive
and Gram negative bacterial pathogens that both impede and
promote wound healing. More research into the production
of new zinc oxide nanoparticles based on HAM proteins
and related proteins, growth factors, and hormones, as well
as their inhibitory effects, survival and growth of pathogenic
bacteria in humans, could pave the way for more efficient
non-antibiotic treatments and wound healing methods and
technologies.
CONCLUSION
The production and development of a wet (PW-HAM)/dry
(PD-HAM) human amniotic membrane wound dressing for
topical use with, in particular, dermal and ocular applications
has been described in the current study. After decellularizing
the amniotic membrane and cross-linking and stabilizing the
proteins with UV/1%glutaraldehyde solution for 20 min, the
wet form of the HAM dressings was made by packing them
in 3 mL isopropyl alcohol, sterilizing them, and keeping them
at room temperature (30◦C) until required. Decellularizing
the membrane, UV irradiating it, lyophilizing/freeze-drying it,
sterilizing it, and storing it at room temperature created the dry
form of HAM. The UP-HAM is a transparent yellowish mass of
flexible membranes with a 42 µm average thickness. Processed,
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decellularized, and dehydrated PW-HAM wound dressings had a
thinner average thickness of 30 µm and lacked nuclear-cellular
structures. Following the decellularization process, a fibrous
basement membrane, discrete bundle of fibrous components
in the stromal spongy layers, microvilli and reticular ridges
remained on a relatively smooth and flat membrane surface,
over a fine matrix. The HAM wound dressings can be kept at
room temperature for 3-5 years, are easy to transport, and are
available all year. The cost of producing a slice of HAM dressing is
low (1.0 US$/cm2). Automation and large-scale HAM membrane
preparation, as well as the development of synthetic membranes,
storage, and transportation of dressings, can all help to develop
advanced technologies, increase membrane production quality,
and lower costs. For a long time, HAM has been used in surgical
reconstruction and tissue engineering. The HAM protein analysis
indicated 360 µg proteins per gram of tissue, with three main
fractions with MWs of 100 kDa, 70 kDa, and 14 kDa, and seven
minor proteins. The 14 kDa protein has antibacterial properties
against human pathogenic bacteria. Antibacterial activity was
observed in HAMP-ZnO nanoparticles (NPs) containing protein
isolated from the human amniotic membrane against Gram
positive and Gram-negative bacteria. Furthermore, HAMP-ZnO
NPs’ anti-biofilm ability was likely found to be proportional
to incubation concentration. Treatment with HAMP-ZnO NPs
inhibited and reduced the thickness of biofilm formation in Gram
positive (S. aureus, S. mutans, E. faecalis, and L. fusiformis) and
Gram-negative bacteria (S. sonnei, P. aeruginosa, P. vulgaris,
and C. freundii). Innovative zinc oxide nanoparticles based
on HAM antimicrobial proteins/peptides, growth factors, and
signaling molecules, metabolites, as well as their synergistic
effects on human bacterial infections, could pave the way for
more successful wound healing methods and technologies, as well
as antibacterial treatment molecules.
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